{"transactions":[{"id":1678118,"issuer":{"id":4562,"kind":"organization","name":"P3 Health Partners Inc."},"owners":[{"id":95128,"kind":"person","name":"Abdou Sherif","position":1,"cik":"0001890129","reported_name":"Abdou Sherif","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2024-01-17T17:26:02.000Z","date":"2024-01-09","kind":"other","planned":false,"acquired":true,"shares":483868,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 3, 2024, the Reporting Person filed a Form 4 reporting the withholding of 483,868 shares of Class A common stock to satisfy tax withholding requirements upon the vesting of restricted stock units. On January 9, 2024, the withholding was rescinded upon election by the Reporting Person to satisfy tax withholding obligations via a cash payment and no shares were withheld."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On January 3, 2024, the Reporting Person filed a Form 4 reporting the withholding of 483,868 shares of Class A common stock to satisfy tax withholding requirements upon the vesting of restricted stock units. On January 9, 2024, the withholding was rescinded upon election by the Reporting Person to satisfy tax withholding obligations via a cash payment and no shares were withheld."}],"balance_after":1608225,"source":{"system":"sec-edgar","filing":"0001628280-24-001540","document":"wk-form4_1705530352.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1890129/000162828024001540/wk-form4_1705530352.xml","form_type":"4"}},{"id":1693327,"issuer":{"id":4562,"kind":"organization","name":"P3 Health Partners Inc."},"owners":[{"id":95128,"kind":"person","name":"Abdou Sherif","position":1,"cik":"0001890129","reported_name":"Abdou Sherif","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2024-01-03T17:30:54.000Z","date":"2023-12-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":483868,"price":1.41,"value":682253.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding requirements on vesting of restricted stock units."}],"balance_after":1124357,"source":{"system":"sec-edgar","filing":"0001628280-24-000268","document":"wk-form4_1704321041.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1890129/000162828024000268/wk-form4_1704321041.xml","form_type":"4"}},{"id":1813057,"issuer":{"id":4562,"kind":"organization","name":"P3 Health Partners Inc."},"owners":[{"id":95128,"kind":"person","name":"Abdou Sherif","position":1,"cik":"0001890129","reported_name":"Abdou Sherif","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-08-08T21:51:50.000Z","date":"2023-08-04","kind":"grant","planned":false,"acquired":true,"shares":1500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\") granted pursuant to the P3 Health Partners Inc. 2021 Incentive Award Plan in full satisfaction of the \"Second Bonus\" set forth in the Transaction Bonus Agreement between Reporting Person, the Issuer and P3 Health Group Management, LLC, dated May 2022.  Each RSU represents a right to receive one share of Class A common stock. The RSUs will be settled in Class A common stock on the earlier of (i) December 31, 2023 and (ii) the closing of the Company's first underwritten offering and sale of common stock."}],"balance_after":1608225,"source":{"system":"sec-edgar","filing":"0001104659-23-089000","document":"tm2323184-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1890129/000110465923089000/tm2323184-4_4seq1.xml","form_type":"4"}},{"id":1891810,"issuer":{"id":4562,"kind":"organization","name":"P3 Health Partners Inc."},"owners":[{"id":95128,"kind":"person","name":"Abdou Sherif","position":1,"cik":"0001890129","reported_name":"Abdou Sherif","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-05-16T18:16:20.000Z","date":"2023-05-12","kind":"purchase","planned":false,"acquired":true,"shares":108225,"price":2.6283,"value":284447.7675,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. The securities were purchased in multiple transactions at per share prices ranging from $2.54 to $2.69, inclusive. The Reporting Person undertakes to provide upon request from the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote."}],"balance_after":108225,"source":{"system":"sec-edgar","filing":"0001104659-23-061505","document":"tm2316004-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1890129/000110465923061505/tm2316004-2_4seq1.xml","form_type":"4"}},{"id":2482576,"issuer":{"id":4562,"kind":"organization","name":"P3 Health Partners Inc."},"owners":[{"id":95128,"kind":"person","name":"Abdou Sherif","position":1,"cik":"0001890129","reported_name":"Abdou Sherif","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Units","published_at":"2021-12-07T21:16:06.000Z","date":"2021-12-03","kind":"grant","acquired":true,"shares":1408437,"ownership":{"direct":false,"nature":"By SA Charitable Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"At the closing of the business combination pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), as described in the Issuer's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on October 28, 2021, as supplemented, the reporting person received Common Units of P3 Health Group, LLC (the \"Common Units\"), a direct subsidiary of the Issuer, as consideration for the common units of P3 Health Group Holdings, LLC. In connection with the receipt of Common Units, each recipient subscribed for an equal number of shares of Class V Common Stock of the Issuer for a purchase price equal to par value."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The Common Units are redeemable at any time by the reporting person for, at the election of the Issuer, newly-issued Class A Common Stock of the Issuer on a one-for-one basis or a cash payment equal to the volume weighted average market price of one share of Class A Common Stock for each Common Unit redeemed. Upon the redemption of any Common Units, a number of shares of Class V Common Stock of the Issuer equal to the number of Common Units that are redeemed will be cancelled by the Issuer for no consideration."},{"field":"shares","element":"transactionShares","label":"F8","text":"Includes 132,571 shares of Class V common stock and 132,571 Common Units of P3 Health Group, LLC being held in escrow following the business combination described above until the resolution of a dispute among the former unitholders of P3 Health Group Holdings, LLC in accordance with the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the closing of the business combination pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), as described in the Issuer's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on October 28, 2021, as supplemented, the reporting person received Common Units of P3 Health Group, LLC (the \"Common Units\"), a direct subsidiary of the Issuer, as consideration for the common units of P3 Health Group Holdings, LLC. In connection with the receipt of Common Units, each recipient subscribed for an equal number of shares of Class V Common Stock of the Issuer for a purchase price equal to par value."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Common Units are redeemable at any time by the reporting person for, at the election of the Issuer, newly-issued Class A Common Stock of the Issuer on a one-for-one basis or a cash payment equal to the volume weighted average market price of one share of Class A Common Stock for each Common Unit redeemed. Upon the redemption of any Common Units, a number of shares of Class V Common Stock of the Issuer equal to the number of Common Units that are redeemed will be cancelled by the Issuer for no consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Common Units are redeemable at any time by the reporting person for, at the election of the Issuer, newly-issued Class A Common Stock of the Issuer on a one-for-one basis or a cash payment equal to the volume weighted average market price of one share of Class A Common Stock for each Common Unit redeemed. Upon the redemption of any Common Units, a number of shares of Class V Common Stock of the Issuer equal to the number of Common Units that are redeemed will be cancelled by the Issuer for no consideration."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F8","text":"Includes 132,571 shares of Class V common stock and 132,571 Common Units of P3 Health Group, LLC being held in escrow following the business combination described above until the resolution of a dispute among the former unitholders of P3 Health Group Holdings, LLC in accordance with the Merger Agreement."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F12","text":"These securities are held by the SA Charitable Trust, a charitable remainder trust of which the reporting person, his spouse and his children serve as trustees, and of which the reporting person and his spouse are beneficiaries."}],"balance_after":1408437,"derivative":{"underlying":"Class A Common Stock","underlying_shares":1408437},"source":{"system":"sec-edgar","filing":"0001104659-21-147358","document":"tm2134662-6_4seq.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1890129/000110465921147358/tm2134662-6_4seq.xml","form_type":"4"}},{"id":2482575,"issuer":{"id":4562,"kind":"organization","name":"P3 Health Partners Inc."},"owners":[{"id":95128,"kind":"person","name":"Abdou Sherif","position":1,"cik":"0001890129","reported_name":"Abdou Sherif","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Units","published_at":"2021-12-07T21:16:06.000Z","date":"2021-12-03","kind":"grant","acquired":true,"shares":3058479,"ownership":{"direct":false,"nature":"By SA 2021 Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"At the closing of the business combination pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), as described in the Issuer's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on October 28, 2021, as supplemented, the reporting person received Common Units of P3 Health Group, LLC (the \"Common Units\"), a direct subsidiary of the Issuer, as consideration for the common units of P3 Health Group Holdings, LLC. In connection with the receipt of Common Units, each recipient subscribed for an equal number of shares of Class V Common Stock of the Issuer for a purchase price equal to par value."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The Common Units are redeemable at any time by the reporting person for, at the election of the Issuer, newly-issued Class A Common Stock of the Issuer on a one-for-one basis or a cash payment equal to the volume weighted average market price of one share of Class A Common Stock for each Common Unit redeemed. Upon the redemption of any Common Units, a number of shares of Class V Common Stock of the Issuer equal to the number of Common Units that are redeemed will be cancelled by the Issuer for no consideration."},{"field":"shares","element":"transactionShares","label":"F6","text":"Includes 287,883 shares of Class V common stock and 287,883 Common Units of P3 Health Group, LLC being held in escrow following the business combination described above until the resolution of a dispute among the former unitholders of P3 Health Group Holdings, LLC in accordance with the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the closing of the business combination pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), as described in the Issuer's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on October 28, 2021, as supplemented, the reporting person received Common Units of P3 Health Group, LLC (the \"Common Units\"), a direct subsidiary of the Issuer, as consideration for the common units of P3 Health Group Holdings, LLC. In connection with the receipt of Common Units, each recipient subscribed for an equal number of shares of Class V Common Stock of the Issuer for a purchase price equal to par value."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Common Units are redeemable at any time by the reporting person for, at the election of the Issuer, newly-issued Class A Common Stock of the Issuer on a one-for-one basis or a cash payment equal to the volume weighted average market price of one share of Class A Common Stock for each Common Unit redeemed. Upon the redemption of any Common Units, a number of shares of Class V Common Stock of the Issuer equal to the number of Common Units that are redeemed will be cancelled by the Issuer for no consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Common Units are redeemable at any time by the reporting person for, at the election of the Issuer, newly-issued Class A Common Stock of the Issuer on a one-for-one basis or a cash payment equal to the volume weighted average market price of one share of Class A Common Stock for each Common Unit redeemed. Upon the redemption of any Common Units, a number of shares of Class V Common Stock of the Issuer equal to the number of Common Units that are redeemed will be cancelled by the Issuer for no consideration."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Includes 287,883 shares of Class V common stock and 287,883 Common Units of P3 Health Group, LLC being held in escrow following the business combination described above until the resolution of a dispute among the former unitholders of P3 Health Group Holdings, LLC in accordance with the Merger Agreement."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F11","text":"These securities are held by the SA 2021 Trust, a trust for the benefit of the reporting person and his children, of which the reporting person and his spouse serve as trustees."}],"balance_after":3058479,"derivative":{"underlying":"Class A Common Stock","underlying_shares":3058479},"source":{"system":"sec-edgar","filing":"0001104659-21-147358","document":"tm2134662-6_4seq.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1890129/000110465921147358/tm2134662-6_4seq.xml","form_type":"4"}},{"id":2482574,"issuer":{"id":4562,"kind":"organization","name":"P3 Health Partners Inc."},"owners":[{"id":95128,"kind":"person","name":"Abdou Sherif","position":1,"cik":"0001890129","reported_name":"Abdou Sherif","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Units","published_at":"2021-12-07T21:16:06.000Z","date":"2021-12-03","kind":"grant","acquired":true,"shares":9626075,"ownership":{"direct":false,"nature":"By SA 2021 GRAT"},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"At the closing of the business combination pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), as described in the Issuer's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on October 28, 2021, as supplemented, the reporting person received Common Units of P3 Health Group, LLC (the \"Common Units\"), a direct subsidiary of the Issuer, as consideration for the common units of P3 Health Group Holdings, LLC. In connection with the receipt of Common Units, each recipient subscribed for an equal number of shares of Class V Common Stock of the Issuer for a purchase price equal to par value."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The Common Units are redeemable at any time by the reporting person for, at the election of the Issuer, newly-issued Class A Common Stock of the Issuer on a one-for-one basis or a cash payment equal to the volume weighted average market price of one share of Class A Common Stock for each Common Unit redeemed. Upon the redemption of any Common Units, a number of shares of Class V Common Stock of the Issuer equal to the number of Common Units that are redeemed will be cancelled by the Issuer for no consideration."},{"field":"shares","element":"transactionShares","label":"F2","text":"Includes 906,068 shares of Class V common stock and 906,068 Common Units of P3 Health Group, LLC being held in escrow following the business combination described below until the resolution of a dispute among the former unitholders of P3 Health Group Holdings, LLC in accordance with the Merger Agreement (as defined below)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the closing of the business combination pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), as described in the Issuer's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on October 28, 2021, as supplemented, the reporting person received Common Units of P3 Health Group, LLC (the \"Common Units\"), a direct subsidiary of the Issuer, as consideration for the common units of P3 Health Group Holdings, LLC. In connection with the receipt of Common Units, each recipient subscribed for an equal number of shares of Class V Common Stock of the Issuer for a purchase price equal to par value."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Common Units are redeemable at any time by the reporting person for, at the election of the Issuer, newly-issued Class A Common Stock of the Issuer on a one-for-one basis or a cash payment equal to the volume weighted average market price of one share of Class A Common Stock for each Common Unit redeemed. Upon the redemption of any Common Units, a number of shares of Class V Common Stock of the Issuer equal to the number of Common Units that are redeemed will be cancelled by the Issuer for no consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Common Units are redeemable at any time by the reporting person for, at the election of the Issuer, newly-issued Class A Common Stock of the Issuer on a one-for-one basis or a cash payment equal to the volume weighted average market price of one share of Class A Common Stock for each Common Unit redeemed. Upon the redemption of any Common Units, a number of shares of Class V Common Stock of the Issuer equal to the number of Common Units that are redeemed will be cancelled by the Issuer for no consideration."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 906,068 shares of Class V common stock and 906,068 Common Units of P3 Health Group, LLC being held in escrow following the business combination described below until the resolution of a dispute among the former unitholders of P3 Health Group Holdings, LLC in accordance with the Merger Agreement (as defined below)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"These securities are held by the SA 2021 GRAT, a grantor retained annuity trust of which the reporting person and his spouse serve as trustees."}],"balance_after":9626075,"derivative":{"underlying":"Class A Common Stock","underlying_shares":9626075},"source":{"system":"sec-edgar","filing":"0001104659-21-147358","document":"tm2134662-6_4seq.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1890129/000110465921147358/tm2134662-6_4seq.xml","form_type":"4"}},{"id":2482573,"issuer":{"id":4562,"kind":"organization","name":"P3 Health Partners Inc."},"owners":[{"id":95128,"kind":"person","name":"Abdou Sherif","position":1,"cik":"0001890129","reported_name":"Abdou Sherif","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Units","published_at":"2021-12-07T21:16:06.000Z","date":"2021-12-03","kind":"grant","acquired":true,"shares":1408437,"ownership":{"direct":false,"nature":"By NA Charitable Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"At the closing of the business combination pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), as described in the Issuer's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on October 28, 2021, as supplemented, the reporting person received Common Units of P3 Health Group, LLC (the \"Common Units\"), a direct subsidiary of the Issuer, as consideration for the common units of P3 Health Group Holdings, LLC. In connection with the receipt of Common Units, each recipient subscribed for an equal number of shares of Class V Common Stock of the Issuer for a purchase price equal to par value."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The Common Units are redeemable at any time by the reporting person for, at the election of the Issuer, newly-issued Class A Common Stock of the Issuer on a one-for-one basis or a cash payment equal to the volume weighted average market price of one share of Class A Common Stock for each Common Unit redeemed. Upon the redemption of any Common Units, a number of shares of Class V Common Stock of the Issuer equal to the number of Common Units that are redeemed will be cancelled by the Issuer for no consideration."},{"field":"shares","element":"transactionShares","label":"F8","text":"Includes 132,571 shares of Class V common stock and 132,571 Common Units of P3 Health Group, LLC being held in escrow following the business combination described above until the resolution of a dispute among the former unitholders of P3 Health Group Holdings, LLC in accordance with the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the closing of the business combination pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), as described in the Issuer's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on October 28, 2021, as supplemented, the reporting person received Common Units of P3 Health Group, LLC (the \"Common Units\"), a direct subsidiary of the Issuer, as consideration for the common units of P3 Health Group Holdings, LLC. In connection with the receipt of Common Units, each recipient subscribed for an equal number of shares of Class V Common Stock of the Issuer for a purchase price equal to par value."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Common Units are redeemable at any time by the reporting person for, at the election of the Issuer, newly-issued Class A Common Stock of the Issuer on a one-for-one basis or a cash payment equal to the volume weighted average market price of one share of Class A Common Stock for each Common Unit redeemed. Upon the redemption of any Common Units, a number of shares of Class V Common Stock of the Issuer equal to the number of Common Units that are redeemed will be cancelled by the Issuer for no consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Common Units are redeemable at any time by the reporting person for, at the election of the Issuer, newly-issued Class A Common Stock of the Issuer on a one-for-one basis or a cash payment equal to the volume weighted average market price of one share of Class A Common Stock for each Common Unit redeemed. Upon the redemption of any Common Units, a number of shares of Class V Common Stock of the Issuer equal to the number of Common Units that are redeemed will be cancelled by the Issuer for no consideration."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F8","text":"Includes 132,571 shares of Class V common stock and 132,571 Common Units of P3 Health Group, LLC being held in escrow following the business combination described above until the resolution of a dispute among the former unitholders of P3 Health Group Holdings, LLC in accordance with the Merger Agreement."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"These securities are held by the NA Charitable Trust, a charitable remainder trust of which the reporting person, his spouse and his children serve as trustees, and of which the reporting person and his spouse are beneficiaries."}],"balance_after":1408437,"derivative":{"underlying":"Class A Common Stock","underlying_shares":1408437},"source":{"system":"sec-edgar","filing":"0001104659-21-147358","document":"tm2134662-6_4seq.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1890129/000110465921147358/tm2134662-6_4seq.xml","form_type":"4"}},{"id":2482572,"issuer":{"id":4562,"kind":"organization","name":"P3 Health Partners Inc."},"owners":[{"id":95128,"kind":"person","name":"Abdou Sherif","position":1,"cik":"0001890129","reported_name":"Abdou Sherif","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Units","published_at":"2021-12-07T21:16:06.000Z","date":"2021-12-03","kind":"grant","acquired":true,"shares":3058479,"ownership":{"direct":false,"nature":"By NA 2021 Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"At the closing of the business combination pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), as described in the Issuer's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on October 28, 2021, as supplemented, the reporting person received Common Units of P3 Health Group, LLC (the \"Common Units\"), a direct subsidiary of the Issuer, as consideration for the common units of P3 Health Group Holdings, LLC. In connection with the receipt of Common Units, each recipient subscribed for an equal number of shares of Class V Common Stock of the Issuer for a purchase price equal to par value."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The Common Units are redeemable at any time by the reporting person for, at the election of the Issuer, newly-issued Class A Common Stock of the Issuer on a one-for-one basis or a cash payment equal to the volume weighted average market price of one share of Class A Common Stock for each Common Unit redeemed. Upon the redemption of any Common Units, a number of shares of Class V Common Stock of the Issuer equal to the number of Common Units that are redeemed will be cancelled by the Issuer for no consideration."},{"field":"shares","element":"transactionShares","label":"F6","text":"Includes 287,883 shares of Class V common stock and 287,883 Common Units of P3 Health Group, LLC being held in escrow following the business combination described above until the resolution of a dispute among the former unitholders of P3 Health Group Holdings, LLC in accordance with the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the closing of the business combination pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), as described in the Issuer's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on October 28, 2021, as supplemented, the reporting person received Common Units of P3 Health Group, LLC (the \"Common Units\"), a direct subsidiary of the Issuer, as consideration for the common units of P3 Health Group Holdings, LLC. In connection with the receipt of Common Units, each recipient subscribed for an equal number of shares of Class V Common Stock of the Issuer for a purchase price equal to par value."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Common Units are redeemable at any time by the reporting person for, at the election of the Issuer, newly-issued Class A Common Stock of the Issuer on a one-for-one basis or a cash payment equal to the volume weighted average market price of one share of Class A Common Stock for each Common Unit redeemed. Upon the redemption of any Common Units, a number of shares of Class V Common Stock of the Issuer equal to the number of Common Units that are redeemed will be cancelled by the Issuer for no consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Common Units are redeemable at any time by the reporting person for, at the election of the Issuer, newly-issued Class A Common Stock of the Issuer on a one-for-one basis or a cash payment equal to the volume weighted average market price of one share of Class A Common Stock for each Common Unit redeemed. Upon the redemption of any Common Units, a number of shares of Class V Common Stock of the Issuer equal to the number of Common Units that are redeemed will be cancelled by the Issuer for no consideration."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Includes 287,883 shares of Class V common stock and 287,883 Common Units of P3 Health Group, LLC being held in escrow following the business combination described above until the resolution of a dispute among the former unitholders of P3 Health Group Holdings, LLC in accordance with the Merger Agreement."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"These securities are held by the NA 2021 Trust, a trust for the benefit of the reporting person and his children, of which the reporting person and his spouse serve as trustees."}],"balance_after":3058479,"derivative":{"underlying":"Class A Common Stock","underlying_shares":3058479},"source":{"system":"sec-edgar","filing":"0001104659-21-147358","document":"tm2134662-6_4seq.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1890129/000110465921147358/tm2134662-6_4seq.xml","form_type":"4"}},{"id":2482571,"issuer":{"id":4562,"kind":"organization","name":"P3 Health Partners Inc."},"owners":[{"id":95128,"kind":"person","name":"Abdou Sherif","position":1,"cik":"0001890129","reported_name":"Abdou Sherif","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Units","published_at":"2021-12-07T21:16:06.000Z","date":"2021-12-03","kind":"grant","acquired":true,"shares":9626075,"ownership":{"direct":false,"nature":"By NA 2021 GRAT"},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"At the closing of the business combination pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), as described in the Issuer's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on October 28, 2021, as supplemented, the reporting person received Common Units of P3 Health Group, LLC (the \"Common Units\"), a direct subsidiary of the Issuer, as consideration for the common units of P3 Health Group Holdings, LLC. In connection with the receipt of Common Units, each recipient subscribed for an equal number of shares of Class V Common Stock of the Issuer for a purchase price equal to par value."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The Common Units are redeemable at any time by the reporting person for, at the election of the Issuer, newly-issued Class A Common Stock of the Issuer on a one-for-one basis or a cash payment equal to the volume weighted average market price of one share of Class A Common Stock for each Common Unit redeemed. Upon the redemption of any Common Units, a number of shares of Class V Common Stock of the Issuer equal to the number of Common Units that are redeemed will be cancelled by the Issuer for no consideration."},{"field":"shares","element":"transactionShares","label":"F2","text":"Includes 906,068 shares of Class V common stock and 906,068 Common Units of P3 Health Group, LLC being held in escrow following the business combination described below until the resolution of a dispute among the former unitholders of P3 Health Group Holdings, LLC in accordance with the Merger Agreement (as defined below)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the closing of the business combination pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), as described in the Issuer's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on October 28, 2021, as supplemented, the reporting person received Common Units of P3 Health Group, LLC (the \"Common Units\"), a direct subsidiary of the Issuer, as consideration for the common units of P3 Health Group Holdings, LLC. In connection with the receipt of Common Units, each recipient subscribed for an equal number of shares of Class V Common Stock of the Issuer for a purchase price equal to par value."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Common Units are redeemable at any time by the reporting person for, at the election of the Issuer, newly-issued Class A Common Stock of the Issuer on a one-for-one basis or a cash payment equal to the volume weighted average market price of one share of Class A Common Stock for each Common Unit redeemed. Upon the redemption of any Common Units, a number of shares of Class V Common Stock of the Issuer equal to the number of Common Units that are redeemed will be cancelled by the Issuer for no consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Common Units are redeemable at any time by the reporting person for, at the election of the Issuer, newly-issued Class A Common Stock of the Issuer on a one-for-one basis or a cash payment equal to the volume weighted average market price of one share of Class A Common Stock for each Common Unit redeemed. Upon the redemption of any Common Units, a number of shares of Class V Common Stock of the Issuer equal to the number of Common Units that are redeemed will be cancelled by the Issuer for no consideration."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 906,068 shares of Class V common stock and 906,068 Common Units of P3 Health Group, LLC being held in escrow following the business combination described below until the resolution of a dispute among the former unitholders of P3 Health Group Holdings, LLC in accordance with the Merger Agreement (as defined below)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These securities are held by the NA 2021 GRAT, a grantor retained annuity trust of which the reporting person and his spouse serve as trustees."}],"balance_after":9626075,"derivative":{"underlying":"Class A Common Stock","underlying_shares":9626075},"source":{"system":"sec-edgar","filing":"0001104659-21-147358","document":"tm2134662-6_4seq.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1890129/000110465921147358/tm2134662-6_4seq.xml","form_type":"4"}},{"id":2482570,"issuer":{"id":4562,"kind":"organization","name":"P3 Health Partners Inc."},"owners":[{"id":95128,"kind":"person","name":"Abdou Sherif","position":1,"cik":"0001890129","reported_name":"Abdou Sherif","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class V Common Stock","published_at":"2021-12-07T21:16:06.000Z","date":"2021-12-03","kind":"grant","acquired":true,"shares":1408437,"price":140.84,"value":198364267.08,"ownership":{"direct":false,"nature":"By SA Charitable Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Upon the redemption of any Common Units (as defined below), a number of shares of Class V Common Stock equal to the number of Common Units that are redeemed will be cancelled by the Issuer for no consideration."},{"field":"shares","element":"transactionShares","label":"F8","text":"Includes 132,571 shares of Class V common stock and 132,571 Common Units of P3 Health Group, LLC being held in escrow following the business combination described above until the resolution of a dispute among the former unitholders of P3 Health Group Holdings, LLC in accordance with the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the closing of the business combination pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), as described in the Issuer's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on October 28, 2021, as supplemented, the reporting person received Common Units of P3 Health Group, LLC (the \"Common Units\"), a direct subsidiary of the Issuer, as consideration for the common units of P3 Health Group Holdings, LLC. In connection with the receipt of Common Units, each recipient subscribed for an equal number of shares of Class V Common Stock of the Issuer for a purchase price equal to par value."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F8","text":"Includes 132,571 shares of Class V common stock and 132,571 Common Units of P3 Health Group, LLC being held in escrow following the business combination described above until the resolution of a dispute among the former unitholders of P3 Health Group Holdings, LLC in accordance with the Merger Agreement."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F12","text":"These securities are held by the SA Charitable Trust, a charitable remainder trust of which the reporting person, his spouse and his children serve as trustees, and of which the reporting person and his spouse are beneficiaries."}],"balance_after":1408437,"source":{"system":"sec-edgar","filing":"0001104659-21-147358","document":"tm2134662-6_4seq.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1890129/000110465921147358/tm2134662-6_4seq.xml","form_type":"4"}},{"id":2482569,"issuer":{"id":4562,"kind":"organization","name":"P3 Health Partners Inc."},"owners":[{"id":95128,"kind":"person","name":"Abdou Sherif","position":1,"cik":"0001890129","reported_name":"Abdou Sherif","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class V Common Stock","published_at":"2021-12-07T21:16:06.000Z","date":"2021-12-03","kind":"grant","acquired":true,"shares":3058479,"price":305.85,"value":935435802.15,"ownership":{"direct":false,"nature":"By SA 2021 Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Upon the redemption of any Common Units (as defined below), a number of shares of Class V Common Stock equal to the number of Common Units that are redeemed will be cancelled by the Issuer for no consideration."},{"field":"shares","element":"transactionShares","label":"F6","text":"Includes 287,883 shares of Class V common stock and 287,883 Common Units of P3 Health Group, LLC being held in escrow following the business combination described above until the resolution of a dispute among the former unitholders of P3 Health Group Holdings, LLC in accordance with the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the closing of the business combination pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), as described in the Issuer's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on October 28, 2021, as supplemented, the reporting person received Common Units of P3 Health Group, LLC (the \"Common Units\"), a direct subsidiary of the Issuer, as consideration for the common units of P3 Health Group Holdings, LLC. In connection with the receipt of Common Units, each recipient subscribed for an equal number of shares of Class V Common Stock of the Issuer for a purchase price equal to par value."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Includes 287,883 shares of Class V common stock and 287,883 Common Units of P3 Health Group, LLC being held in escrow following the business combination described above until the resolution of a dispute among the former unitholders of P3 Health Group Holdings, LLC in accordance with the Merger Agreement."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F11","text":"These securities are held by the SA 2021 Trust, a trust for the benefit of the reporting person and his children, of which the reporting person and his spouse serve as trustees."}],"balance_after":3058479,"source":{"system":"sec-edgar","filing":"0001104659-21-147358","document":"tm2134662-6_4seq.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1890129/000110465921147358/tm2134662-6_4seq.xml","form_type":"4"}},{"id":2482568,"issuer":{"id":4562,"kind":"organization","name":"P3 Health Partners Inc."},"owners":[{"id":95128,"kind":"person","name":"Abdou Sherif","position":1,"cik":"0001890129","reported_name":"Abdou Sherif","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class V Common Stock","published_at":"2021-12-07T21:16:06.000Z","date":"2021-12-03","kind":"grant","acquired":true,"shares":9626075,"price":962.61,"value":9266156055.75,"ownership":{"direct":false,"nature":"By SA 2021 GRAT"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Upon the redemption of any Common Units (as defined below), a number of shares of Class V Common Stock equal to the number of Common Units that are redeemed will be cancelled by the Issuer for no consideration."},{"field":"shares","element":"transactionShares","label":"F2","text":"Includes 906,068 shares of Class V common stock and 906,068 Common Units of P3 Health Group, LLC being held in escrow following the business combination described below until the resolution of a dispute among the former unitholders of P3 Health Group Holdings, LLC in accordance with the Merger Agreement (as defined below)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the closing of the business combination pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), as described in the Issuer's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on October 28, 2021, as supplemented, the reporting person received Common Units of P3 Health Group, LLC (the \"Common Units\"), a direct subsidiary of the Issuer, as consideration for the common units of P3 Health Group Holdings, LLC. In connection with the receipt of Common Units, each recipient subscribed for an equal number of shares of Class V Common Stock of the Issuer for a purchase price equal to par value."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 906,068 shares of Class V common stock and 906,068 Common Units of P3 Health Group, LLC being held in escrow following the business combination described below until the resolution of a dispute among the former unitholders of P3 Health Group Holdings, LLC in accordance with the Merger Agreement (as defined below)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"These securities are held by the SA 2021 GRAT, a grantor retained annuity trust of which the reporting person and his spouse serve as trustees."}],"balance_after":9626075,"source":{"system":"sec-edgar","filing":"0001104659-21-147358","document":"tm2134662-6_4seq.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1890129/000110465921147358/tm2134662-6_4seq.xml","form_type":"4"}},{"id":2482567,"issuer":{"id":4562,"kind":"organization","name":"P3 Health Partners Inc."},"owners":[{"id":95128,"kind":"person","name":"Abdou Sherif","position":1,"cik":"0001890129","reported_name":"Abdou Sherif","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class V Common Stock","published_at":"2021-12-07T21:16:06.000Z","date":"2021-12-03","kind":"grant","acquired":true,"shares":1408437,"price":140.84,"value":198364267.08,"ownership":{"direct":false,"nature":"By NA Charitable Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Upon the redemption of any Common Units (as defined below), a number of shares of Class V Common Stock equal to the number of Common Units that are redeemed will be cancelled by the Issuer for no consideration."},{"field":"shares","element":"transactionShares","label":"F8","text":"Includes 132,571 shares of Class V common stock and 132,571 Common Units of P3 Health Group, LLC being held in escrow following the business combination described above until the resolution of a dispute among the former unitholders of P3 Health Group Holdings, LLC in accordance with the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the closing of the business combination pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), as described in the Issuer's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on October 28, 2021, as supplemented, the reporting person received Common Units of P3 Health Group, LLC (the \"Common Units\"), a direct subsidiary of the Issuer, as consideration for the common units of P3 Health Group Holdings, LLC. In connection with the receipt of Common Units, each recipient subscribed for an equal number of shares of Class V Common Stock of the Issuer for a purchase price equal to par value."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F8","text":"Includes 132,571 shares of Class V common stock and 132,571 Common Units of P3 Health Group, LLC being held in escrow following the business combination described above until the resolution of a dispute among the former unitholders of P3 Health Group Holdings, LLC in accordance with the Merger Agreement."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"These securities are held by the NA Charitable Trust, a charitable remainder trust of which the reporting person, his spouse and his children serve as trustees, and of which the reporting person and his spouse are beneficiaries."}],"balance_after":1408437,"source":{"system":"sec-edgar","filing":"0001104659-21-147358","document":"tm2134662-6_4seq.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1890129/000110465921147358/tm2134662-6_4seq.xml","form_type":"4"}},{"id":2482566,"issuer":{"id":4562,"kind":"organization","name":"P3 Health Partners Inc."},"owners":[{"id":95128,"kind":"person","name":"Abdou Sherif","position":1,"cik":"0001890129","reported_name":"Abdou Sherif","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class V Common Stock","published_at":"2021-12-07T21:16:06.000Z","date":"2021-12-03","kind":"grant","acquired":true,"shares":3058479,"price":305.85,"value":935435802.15,"ownership":{"direct":false,"nature":"By NA 2021 Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Upon the redemption of any Common Units (as defined below), a number of shares of Class V Common Stock equal to the number of Common Units that are redeemed will be cancelled by the Issuer for no consideration."},{"field":"shares","element":"transactionShares","label":"F6","text":"Includes 287,883 shares of Class V common stock and 287,883 Common Units of P3 Health Group, LLC being held in escrow following the business combination described above until the resolution of a dispute among the former unitholders of P3 Health Group Holdings, LLC in accordance with the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the closing of the business combination pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), as described in the Issuer's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on October 28, 2021, as supplemented, the reporting person received Common Units of P3 Health Group, LLC (the \"Common Units\"), a direct subsidiary of the Issuer, as consideration for the common units of P3 Health Group Holdings, LLC. In connection with the receipt of Common Units, each recipient subscribed for an equal number of shares of Class V Common Stock of the Issuer for a purchase price equal to par value."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Includes 287,883 shares of Class V common stock and 287,883 Common Units of P3 Health Group, LLC being held in escrow following the business combination described above until the resolution of a dispute among the former unitholders of P3 Health Group Holdings, LLC in accordance with the Merger Agreement."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"These securities are held by the NA 2021 Trust, a trust for the benefit of the reporting person and his children, of which the reporting person and his spouse serve as trustees."}],"balance_after":3058479,"source":{"system":"sec-edgar","filing":"0001104659-21-147358","document":"tm2134662-6_4seq.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1890129/000110465921147358/tm2134662-6_4seq.xml","form_type":"4"}},{"id":2482565,"issuer":{"id":4562,"kind":"organization","name":"P3 Health Partners Inc."},"owners":[{"id":95128,"kind":"person","name":"Abdou Sherif","position":1,"cik":"0001890129","reported_name":"Abdou Sherif","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class V Common Stock","published_at":"2021-12-07T21:16:06.000Z","date":"2021-12-03","kind":"grant","acquired":true,"shares":9626075,"price":962.61,"value":9266156055.75,"ownership":{"direct":false,"nature":"By NA 2021 GRAT"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Upon the redemption of any Common Units (as defined below), a number of shares of Class V Common Stock equal to the number of Common Units that are redeemed will be cancelled by the Issuer for no consideration."},{"field":"shares","element":"transactionShares","label":"F2","text":"Includes 906,068 shares of Class V common stock and 906,068 Common Units of P3 Health Group, LLC being held in escrow following the business combination described below until the resolution of a dispute among the former unitholders of P3 Health Group Holdings, LLC in accordance with the Merger Agreement (as defined below)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the closing of the business combination pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), as described in the Issuer's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on October 28, 2021, as supplemented, the reporting person received Common Units of P3 Health Group, LLC (the \"Common Units\"), a direct subsidiary of the Issuer, as consideration for the common units of P3 Health Group Holdings, LLC. In connection with the receipt of Common Units, each recipient subscribed for an equal number of shares of Class V Common Stock of the Issuer for a purchase price equal to par value."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 906,068 shares of Class V common stock and 906,068 Common Units of P3 Health Group, LLC being held in escrow following the business combination described below until the resolution of a dispute among the former unitholders of P3 Health Group Holdings, LLC in accordance with the Merger Agreement (as defined below)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These securities are held by the NA 2021 GRAT, a grantor retained annuity trust of which the reporting person and his spouse serve as trustees."}],"balance_after":9626075,"source":{"system":"sec-edgar","filing":"0001104659-21-147358","document":"tm2134662-6_4seq.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1890129/000110465921147358/tm2134662-6_4seq.xml","form_type":"4"}}]}